Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)

被引：0
|
作者：
Surmeli, Zeki
Bozkurt, Emir
Ozer, Ozge
Atmaca, Harika
Kisim, Asli
Uzunoglu, Selim
Uslu, Ruchan
Karaca, Burcak
机构：
[1] Ege Univ, Tulay Aktas Oncol Hosp, Dept Med Oncol, Izmir, Turkey
[2] Celal Bayar Univ, Fac Sci & Letters, Dept Mol Biol, Manisa, Turkey
[3] Celal Bayar Univ, Sch Med, Dept Med Biol, Manisa, Turkey
[4] Ege Univ, Dept Med Oncol, Izmir, Turkey
[5] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16105
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Blends of genistein and γ-tocotrienol synergistically suppress the proliferation of DU145, PC-3, and LNCaP human prostate cancer cells
    Mo, HB
    [J]. FASEB JOURNAL, 2002, 16 (05): : A1003 - A1003
  • [42] Downregulation of urokinase plasminogen activator and matrix metalloproteinases and upregulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145
    Roomi, M.
    Roomi, Nusrath
    Rath, Matthias
    Niedzwiecki, Aleksandra
    [J]. CANCER RESEARCH, 2009, 69
  • [43] Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol
    Karaca, Burcak
    Kucukzeybek, Yuksel
    Gorumlu, Gurbuz
    Erten, Cigdem
    Gul, Mustafa K.
    Cengiz, Ercument
    Atmaca, Harika
    Uzunoglu, Selim
    Sanli, Ulus A.
    Karabulut, Bulent
    Uslu, Ruchan
    [J]. EUROPEAN CYTOKINE NETWORK, 2008, 19 (04) : 176 - 184
  • [44] γ-T3 and α-TEA reduce the amount of docetaxel required to decrease cell viability in human prostate cancer cells and enhance the efficacy of docetaxel in the treatment of drug-resistant cells
    Asay, Spencer
    Graham, Andrew
    Rankin, Mason
    Hollingsworth, Sydney
    Lindstrom, Elijah
    Burke, Lexady
    Barnes, Bradley
    Oblad, Richard
    Michaelis, David
    Kenealey, Jason
    [J]. FASEB JOURNAL, 2020, 34
  • [45] Hypericum perforatum L. EXTRACTS EXERT CYTOTOXIC EFFECTS AND SHOW DIFFERENT MIRNA SIGNATURES IN PC-3 AND DU 145 PROSTATE CANCER CELLS
    Petrovic, Nina
    Ergun, Sercan
    Crnogorac, Marija Dordic
    Stanojkovic, Tatjana
    Malisic, Emina
    Matic, Ivana Z.
    [J]. GENETIKA-BELGRADE, 2022, 54 (03): : 1249 - 1270
  • [46] Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5
    Ouyang, Dong-Yun
    Xu, Li-Hui
    He, Xian-Hui
    Zhang, Yan-Ting
    Zeng, Long-Hui
    Cai, Ji-Ye
    Ren, Shuai
    [J]. AUTOPHAGY, 2013, 9 (01) : 20 - 32
  • [47] Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor
    Mori, S
    Murakami-Mori, K
    Bonavida, A
    [J]. ANTICANCER RESEARCH, 1999, 19 (2A) : 1011 - 1015
  • [48] Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells
    Tenta, R
    Tiblalexi, D
    Sotiriou, E
    Lembessis, P
    Manoussakis, M
    Koutsilieris, M
    [J]. PROSTATE, 2004, 59 (02): : 120 - 131
  • [49] Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells
    Tenta, R
    Sourla, A
    Lembessis, P
    Luu-The, V
    Koutsilieris, M
    [J]. HORMONE AND METABOLIC RESEARCH, 2005, 37 (10) : 593 - 601
  • [50] Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy
    Sowery, Richard D.
    Hadaschik, Boris A.
    So, Alan I.
    Zoubeidi, Amina
    Fazli, Ladan
    Hurtado-Coll, Antonio
    Gleave, Martin E.
    [J]. BJU INTERNATIONAL, 2008, 102 (03) : 389 - 397
12345